Valeant Approved to Buy Dendreon Assets for $495 Million

A bankruptcy judge Friday approved the sale of the assets of Dendreon Corp., a troubled cancer drug maker, to Valeant Pharmaceuticals International Inc. for $495 million.



from WSJ.com: US Business http://ift.tt/1FEJVWZ

via IFTTT